Conversations in Care: Sharing Information on Treatment Strategies for Menopausal Vasomotor Symptoms
SmartMobile(TM)
Premiere Date: Tuesday, May 1, 2012This activity offers CE credit for:
- Physicians (CME)
- Pharmacists (ACPE)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Monday, September 1, 2014
Note: Credit Is No Longer Available
 | Holly L. Thacker, MD, FACP Director, Center for Specialized Womens Health Associate Professor of Surgery Cleveland Clinic Lerner College of Medicine-CWRU Cleveland, OH |
Co-provided by
Symptoms associated with menopause include hot flashes and night sweats, collectively known as vasomotor symptoms (VMS); vaginal dryness; mood and sleep disturbances; and somatic complaints. Of these, VMS constitute the most common menopausal complaint, the main reason that women seek medical care. Yet, despite the significance of this complaint in terms of prevalence and morbidity, data support that menopausal VMS is undertreated. Thus, important opportunities exist for you to improve care and change clinical outcomes for these women.
This CMEO SmartMobile™, designed to be a concise, digestible, CME/CE activity optimized for viewing on your smart device, provides pearls for practice related to managing menopause-associated VMS. It explores building a therapeutic alliance with women in midlife, using evidence-based findings to guide treatment recommendations for hormonal and nonhormonal therapies, and evaluating how emerging therapies will fit into the therapeutic toolbox.
To allow learners to meet the designated learning objectives of the activity so that clinicians more confidently offer accurate and timely counseling to women who are experiencing or are soon to experience menopause-associated vasomotor symptoms.
At the end of this CE activity, participants should be able to:
- Evaluate the rationales for existing treatment recommendations and recent expert thought supporting the use of hormone therapy for moderate to severe, menopause-associated vasomotor symptoms (VMS).
- Identify key messages to deliver when counseling women on the efficacy and safety of hormonal therapy for menopause-associated VMS.
- Identify key messages to deliver when counseling women on the efficacy and safety of nonhormonal therapy for menopause-associated VMS, including complementary and alternative strategies and emerging therapies.
Supported by an educational grant from Pfizer Inc.
Physicians and other health care professionals who provide gynecologic or primary care to women in midlife.
CME Credit (Physicians):
USF Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hours (0.05 CEUs)
Universal Activity Number: 0376-0000-13-021-H01-P (recorded programs)
Activity Type: knowledge-based
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure of Relevant Financial Relationships with Commercial Interests
USF Health and CME Outfitters, LLC, adhere to the ACCME Standards, as well as those of the ACPE, APA, and ANCC, regarding commercial support of continuing medical education. It is the policy of USF Health and CME Outfitters, LLC, that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
USF Health and CME Outfitters will identify, review, and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist between the following individuals and commercial interests:
Dr. Thacker has disclosed that she serves as a consultant to Myriad Genetic Laboratories, Inc., Boehringer Ingelheim Pharmaceuticals Inc. She serves on the speakers bureaus of Amgen Inc., Novartis Pharmaceuticals Corporation; Warner Chilcott; Bayer Corporation; sanofi-aventis.
Disclosures were obtained from the planning committee members and are on file in the USF Health Office of Continuing Professional Development (OCPD) for review. Disclosures were obtained from the USF Health OCPD staff: Nothing to Disclose.
Sarah L. Froman, MD (content/peer review) has nothing to disclose.
Monique Johnson, MD, CCMEP (planning committee) has nothing to disclose.
Sharon Tordoff, CCMEP (planning committee) has nothing to disclose.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has nothing to disclose.
Sandra Haas Binford, MAEd (planning committee) has nothing to disclose.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
USF Health, CME Outfitters, LLC, the faculty, and Pfizer do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Equal Opportunity Statement:
Events, activities, programs and facilities of the University of South Florida are available to all without regard to race, color, marital status, gender, sexual orientation, religion, national origin, disability, age, Vietnam or disabled veteran status as provided by law and in accordance with the university's respect for personal dignity.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
PLP-047-050112-02
